Merrill J. Egorin - Concepedia

Author

Merrill J. Egorin

Also Known As

Egorin, Merrill J., M EGORIN, M Egorin, M J Egorin, M. Egorin, M. J. Egorin, M.J Egorin, M.J. Egorin, MERRILL J. EGORIN, MERRILL J. EGORIN

474

Publications

21.6K

Citations

H-Index

210

Concepts

All Affiliations

UPMC Hillman Cancer Center University of Pittsburgh University of Maryland, Baltimore National Cancer Institute University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

About

Merrill J. Egorin is an author at UPMC Hillman Cancer Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	165	10.4K
2	Health Sciences	18	25	1.1K
3	Natural Sciences	13	18	540
4	Engineering	7	7	175
5	Humanities	1	1	37

Merrill J. Egorin

275

Publications

20.7K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer Kenneth P. Olive, Michael A. Jacobetz, Christian J. Davidson, Science Tumor BiologyOncologyPancreatic CancerMedicinePharmacology	2009	3.1K
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. Luca Gianni, Christine M. Kearns, Antonio Giani, Journal of Clinical Oncology	1995	559
Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Ian F. Tannock, Carol Lee, Jonathon K Tunggal, PubMed	2002	516
Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08 Patrick Y. Wen, W.K. Alfred Yung, Kathleen R. Lamborn, Clinical Cancer Research	2006	426
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. Duncan I. Jodrell, Merrill J. Egorin, Renzo Canetta, Journal of Clinical Oncology	1992	381
Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme David A. Reardon, Merrill J. Egorin, Jennifer A. Quinn, Journal of Clinical Oncology	2005	330
A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection John D. Hamilton, Pamela Hartigan, Michael S. Simberkoff, New England Journal of Medicine	1992	329
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? Michael Glantz, Bernard F. Cole, Lawrence D. Recht, Journal of Clinical Oncology	1998	322
Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function. Merrill J. Egorin, David A. Van Echo, Stuart J. Tipping, PubMed PharmacotherapyPharmacokineticsGenitourinary CancerDrug MonitoringRenal Excretion	1984	305
Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour Infusion Kenneth B. Ain, Merrill J. Egorin, Philip A. DeSimone Thyroid	2000	297

Page 1